Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pulmatrix Inc
PULMCurrent price
2.2 USD
+0.08 USD (+3.77%)
Last closed
2.18 USD
Company
www.pulmatrix.com
ISIN
US74584P3010
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 341 083 USD
Yield for 12 month
+1.38 %
1Y
3Y
5Y
10Y
15Y
PULM
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts. Address: 36 Crosby Drive, Bedford, MA, United States, 01730
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10 USDP/E ratio
–Dividend Yield
–Current Year
+7 298 000 USD
Last Year
+6 071 000 USD
Current Quarter
+1 552 000 USD
Last Quarter
+5 885 000 USD
Current Year
+5 823 000 USD
Last Year
+6 071 000 USD
Current Quarter
+1 391 000 USD
Last Quarter
+5 611 000 USD
Key Figures PULM
1 year
3 years
5 years
10 years
EBITDA
-11 142 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-29.99 %
PEG Ratio
–
Return On Equity TTM
-58.99 %
Wall Street Target Price
10 USD
Revenue TTM
11 392 000 USD
Book Value
3.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15.8 %
Dividend Yield
–
Gross Profit TTM
6 071 000 USD
Earnings per share
-2.98 USD
Diluted Eps TTM
-2.98 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-95.18 %
Dividend Analytics PULM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PULM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
01.03.2022
Dividend Date
06.02.2019
Stock Valuation PULM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.0047
Price Sales TTM
0.6444
Enterprise Value EBITDA
1.5719
Price Book MRQ
0.5515
Financials PULM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PULM
For 52 weeks
1.55 USD
2.75 USD
50 Day MA
2.09 USD
Shares Short Prior Month
8 082
200 Day MA
1.95 USD
Short Ratio
0.38
Shares Short
5 113
Short Percent
0.15 %
BeatStart